Exact Mass: 331.0583

Exact Mass Matches: 331.0583

Found 53 metabolites which its exact mass value is equals to given mass value 331.0583, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2'-Deoxyadenosine 5'-phosphate

{[(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O6P (331.0682)


Deoxyadenosine monophosphate (dAMP), also known as deoxyadenylic acid or deoxyadenylate in its conjugate acid and conjugate base forms, respectively, is a derivative of the common nucleic acid AMP, or adenosine monophosphate, in which the -OH (hydroxyl) group on the 2 carbon on the nucleotides pentose has been reduced to just a hydrogen atom (hence the "deoxy-" part of the name). Additionally, the monophosphate of the name indicates that two of the phosphoryl groups of GTP have been removed, most likely by hydrolysis. It is a monomer used in DNA. Adenosine is a nucleoside comprised of adenine attached to a ribose (ribofuranose) moiety via a -N9-glycosidic bond. Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS 2′-Deoxyadenosine 5′-monophosphate, a nucleic acid AMP derivative, is a deoxyribonucleotide found in DNA. 2′-Deoxyadenosine 5′-monophosphate can be used to study adenosine-based interactions during DNA synthesis and DNA damage[1]. 2′-Deoxyadenosine 5′-monophosphate, a nucleic acid AMP derivative, is a deoxyribonucleotide found in DNA. 2′-Deoxyadenosine 5′-monophosphate can be used to study adenosine-based interactions during DNA synthesis and DNA damage[1].

   

Piroxicam

4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1λ⁶,2-benzothiazine-3-carboxamide

C15H13N3O4S (331.0627)


Piroxicam is only found in individuals that have used or taken this drug. It is a cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. [PubChem]The antiinflammatory effect of Piroxicam may result from the reversible inhibition of cyclooxygenase, causing the peripheral inhibition of prostaglandin synthesis. The prostaglandins are produced by an enzyme called Cox-1. Piroxicam blocks the Cox-1 enzyme, resulting into the disruption of production of prostaglandins. Piroxicam also inhibits the migration of leukocytes into sites of inflammation and prevents the formation of thromboxane A2, an aggregating agent, by the platelets. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AC - Oxicams S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BC - Antiinflammatory agents, non-steroids D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents KEIO_ID P068; [MS2] KO009199 D004791 - Enzyme Inhibitors KEIO_ID P068

   

2'-Deoxyadenosine 3'-monophosphate

{[5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C10H14N5O6P (331.0682)


   

Fenbendazole sulfone

N-[6-(Benzenesulphonyl)-1H-1,3-benzodiazol-2-yl]methoxycarboximidic acid

C15H13N3O4S (331.0627)


   

2-Methyl-1,1,4-trioxo-N-(2-pyridinyl)-3H-1$l^{6},2-benzothiazine-3-carboxamide

2-methyl-1,1,4-trioxo-N-(pyridin-2-yl)-3,4-dihydro-2H-1lambda6,2-benzothiazine-3-carboxamide

C15H13N3O4S (331.0627)


   

Tibric acid

2-Chloro-5-[(3,5-dimethylpiperidin-1-yl)sulphonyl]benzoic acid

C14H18ClNO4S (331.0645)


   

Zonampanel

(2,3-Dioxo-7-(1H-imidazol-1-yl)-6-nitro-1,2,3,4-tetrahydro-1-quinoxalinyl)acetic acid monohydrate

C13H9N5O6 (331.0553)


   

Fenbendazole sulfone

Fenbendazole sulfone

C15H13N3O4S (331.0627)


   
   

(R)-2-(2-Amino-O6-phosphono-2-desoxy-D-glucose-3-yloxy)-propionsaeure|2-Amino-O3-((R)-1-carboxy-aethyl)-O6-phosphono-2-desoxy-D-glucose|2-amino-O3-((R)-1-carboxy-ethyl)-O6-phosphono-2-deoxy-D-glucose|Muramsaeure-6-phosphat|O6-Phosphono-muramsaeure

(R)-2-(2-Amino-O6-phosphono-2-desoxy-D-glucose-3-yloxy)-propionsaeure|2-Amino-O3-((R)-1-carboxy-aethyl)-O6-phosphono-2-desoxy-D-glucose|2-amino-O3-((R)-1-carboxy-ethyl)-O6-phosphono-2-deoxy-D-glucose|Muramsaeure-6-phosphat|O6-Phosphono-muramsaeure

C9H18NO10P (331.0668)


   
   

Deoxyadenosine monophosphate

2-DEOXYADENOSINE-5-monophosphoric acid

C10H14N5O6P (331.0682)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS relative retention time with respect to 9-anthracene Carboxylic Acid is 0.057 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.056 2′-Deoxyadenosine 5′-monophosphate, a nucleic acid AMP derivative, is a deoxyribonucleotide found in DNA. 2′-Deoxyadenosine 5′-monophosphate can be used to study adenosine-based interactions during DNA synthesis and DNA damage[1]. 2′-Deoxyadenosine 5′-monophosphate, a nucleic acid AMP derivative, is a deoxyribonucleotide found in DNA. 2′-Deoxyadenosine 5′-monophosphate can be used to study adenosine-based interactions during DNA synthesis and DNA damage[1].

   

piroxicam

Piroxicam (Feldene)

C15H13N3O4S (331.0627)


A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide with the exocyclic nitrogen of 2-aminopyridine. A non-steroidal anti-inflammatory drug of the oxicam class, it is used to relieve pain and works by preventing the production of endogenous prostaglandins involved in the mediation of pain, stiffness, tenderness and swelling. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AC - Oxicams S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BC - Antiinflammatory agents, non-steroids D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

2-Deoxyadenosine-5-monophosphate

2-Deoxyadenosine-5-monophosphate

C10H14N5O6P (331.0682)


   

2-Deoxyadenosine 5-monophosphate

2-Deoxyadenosine 5-monophosphate

C10H14N5O6P (331.0682)


A purine 2-deoxyribonucleoside 5-monophosphate having adenine as the nucleobase.

   

2-Deoxyadenosine 5-phosphate

2-Deoxyadenosine 5-phosphate

C10H14N5O6P (331.0682)


   
   

3-[3-(4-chlorophenoxy)-2-oxopyrrolidin-1-yl]benzoic acid

3-[3-(4-chlorophenoxy)-2-oxopyrrolidin-1-yl]benzoic acid

C17H14ClNO4 (331.0611)


   

5-HYDROXY-1-TOSYL-1H-INDOLE-3-CARBOXYLIC ACID

5-HYDROXY-1-TOSYL-1H-INDOLE-3-CARBOXYLIC ACID

C16H13NO5S (331.0514)


   

5-Bromo-2-((tert-Butyldimethylsilyloxy)methyl)-3-methoxypyridine

5-Bromo-2-((tert-Butyldimethylsilyloxy)methyl)-3-methoxypyridine

C13H22BrNO2Si (331.0603)


   

N-Benzyl-2-bromo-N-phenylbutanamide

N-Benzyl-2-bromo-N-phenylbutanamide

C17H18BrNO (331.0572)


   

tert-butyl N-[3-bromo-1-(3-fluorophenyl)propyl]carbamate

tert-butyl N-[3-bromo-1-(3-fluorophenyl)propyl]carbamate

C14H19BrFNO2 (331.0583)


   

tert-butyl N-[3-bromo-1-(4-fluorophenyl)propyl]carbamate

tert-butyl N-[3-bromo-1-(4-fluorophenyl)propyl]carbamate

C14H19BrFNO2 (331.0583)


   

Glymidine sodium

Glymidine sodium

C13H14N3NaO4S (331.0603)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

   

tert-butyl N-[3-bromo-1-(2-fluorophenyl)propyl]carbamate

tert-butyl N-[3-bromo-1-(2-fluorophenyl)propyl]carbamate

C14H19BrFNO2 (331.0583)


   

3-(4-CHLORO-BENZENESULFONYL)-AZETIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(4-CHLORO-BENZENESULFONYL)-AZETIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C14H18ClNO4S (331.0645)


   

2-deoxyadenosine 3-monophosphate

2-deoxyadenosine 3-monophosphate

C10H14N5O6P (331.0682)


   

5-(benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one

5-(benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one

C17H14ClNO4 (331.0611)


   

3-INDOXYL-β-D-GLUCURONIC ACID, SODIUM SALT

3-INDOXYL-β-D-GLUCURONIC ACID, SODIUM SALT

C14H14NNaO7 (331.0668)


   

6-benzyloxy-8-(2-chloro-acetyl)-4H-benzo[1,4]oxazin-3-one

6-benzyloxy-8-(2-chloro-acetyl)-4H-benzo[1,4]oxazin-3-one

C17H14ClNO4 (331.0611)


   

N-(3-CHLOROPHENYL)-2-(5-(3-FLUOROPHENYL)-1,2,4-OXADIAZOL-3-YL)ACETAMIDE

N-(3-CHLOROPHENYL)-2-(5-(3-FLUOROPHENYL)-1,2,4-OXADIAZOL-3-YL)ACETAMIDE

C16H11ClFN3O2 (331.0524)


   

Zonampanel

Zonampanel

C13H9N5O6 (331.0553)


C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant C26170 - Protective Agent > C1509 - Neuroprotective Agent Zonampanel (YM 872) is a selective antagonist of the glutamate receptor subtype, α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor.

   

3-Deoxyadenosine-5-monophosphate

3-Deoxyadenosine-5-monophosphate

C10H14N5O6P (331.0682)


   

2-Chloro-5-(3,5-dimethylpiperidinosulphonyl)benzoic acid

2-Chloro-5-(3,5-dimethylpiperidinosulphonyl)benzoic acid

C14H18ClNO4S (331.0645)


   

2-Methyl-1,1,4-trioxo-N-(2-pyridinyl)-3H-1$l^{6},2-benzothiazine-3-carboxamide

2-Methyl-1,1,4-trioxo-N-(2-pyridinyl)-3H-1$l^{6},2-benzothiazine-3-carboxamide

C15H13N3O4S (331.0627)


   

(5-Hydroxy-6-Methyl-4-{[(3-Oxo-2,3-Dihydro-1,2-Oxazol-4-Yl)amino]methyl}pyridin-3-Yl)methyl Dihydrogen Phosphate

(5-Hydroxy-6-Methyl-4-{[(3-Oxo-2,3-Dihydro-1,2-Oxazol-4-Yl)amino]methyl}pyridin-3-Yl)methyl Dihydrogen Phosphate

C11H14N3O7P (331.0569)


   

[5-Hydroxy-6-Methyl-4-({[(4e)-3-Oxo-1,2-Oxazolidin-4-Ylidene]amino}methyl)pyridin-3-Yl]methyl Dihydrogen Phosphate

[5-Hydroxy-6-Methyl-4-({[(4e)-3-Oxo-1,2-Oxazolidin-4-Ylidene]amino}methyl)pyridin-3-Yl]methyl Dihydrogen Phosphate

C11H14N3O7P (331.0569)


   

8-Bromo-3-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol

8-Bromo-3-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol

C17H18BrNO (331.0572)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D004791 - Enzyme Inhibitors > D000067956 - Adenylyl Cyclase Inhibitors

   

4-(4-chlorophenyl)-3-[(4-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione

4-(4-chlorophenyl)-3-[(4-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione

C16H14ClN3OS (331.0546)


   

2-(2-Chlorophenyl)-2-oxoethyl 3-(acetylamino)benzoate

2-(2-Chlorophenyl)-2-oxoethyl 3-(acetylamino)benzoate

C17H14ClNO4 (331.0611)


   

5-[(1,3-Benzodioxol-5-ylamino)methylidene]-1-cyclopropyl-2-sulfanylidene-1,3-diazinane-4,6-dione

5-[(1,3-Benzodioxol-5-ylamino)methylidene]-1-cyclopropyl-2-sulfanylidene-1,3-diazinane-4,6-dione

C15H13N3O4S (331.0627)


   

2-[2-(4-Methoxyphenyl)-2-oxoethyl]-1,1-dioxo-1,2-benzothiazol-3-one

2-[2-(4-Methoxyphenyl)-2-oxoethyl]-1,1-dioxo-1,2-benzothiazol-3-one

C16H13NO5S (331.0514)


   

[(2S,3R,4R)-4-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methyl dihydrogen phosphate

[(2S,3R,4R)-4-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methyl dihydrogen phosphate

C10H14N5O6P (331.0682)


   

N-[4-methyl-5-[2-(2-pyridinylamino)-4-thiazolyl]-2-thiazolyl]acetamide

N-[4-methyl-5-[2-(2-pyridinylamino)-4-thiazolyl]-2-thiazolyl]acetamide

C14H13N5OS2 (331.0561)


   

2-(3-thiophenyl)acetic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester

2-(3-thiophenyl)acetic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester

C16H13NO5S (331.0514)


   

(2Z)-2-[(2,4-dimethoxyphenyl)methylidene]-6-methyl-[1,3]thiazolo[3,2-b][1,2,4]triazine-3,7-dione

(2Z)-2-[(2,4-dimethoxyphenyl)methylidene]-6-methyl-[1,3]thiazolo[3,2-b][1,2,4]triazine-3,7-dione

C15H13N3O4S (331.0627)


   

3-(4-chlorophenyl)-N-cyclopropyl-1-methyl-5-thieno[2,3-c]pyrazolecarboxamide

3-(4-chlorophenyl)-N-cyclopropyl-1-methyl-5-thieno[2,3-c]pyrazolecarboxamide

C16H14ClN3OS (331.0546)


   

2-[2-(3-bromophenoxy)ethyl]-3,4-dihydro-1H-isoquinoline

2-[2-(3-bromophenoxy)ethyl]-3,4-dihydro-1H-isoquinoline

C17H18BrNO (331.0572)


   

SKF-83566

SKF-83566

C17H18BrNO (331.0572)


SKF-83566 is a potent,?blood-brain permeable and orally active D1-like dopamine receptor (D1DR)?antagonist and a weaker competitive antagonist at the vascular 5-HT2?receptor (Ki=11 nM)[1][3]. SKF-83566 is a competitive DAT (dopamine transporter) inhibitor with an IC50?of 5.7 μM[2]. SKF-83566 also shows selective inhibition for adenylyl cyclase 2 (AC2) over AC1 and AC5 in the isolated rabbit thoracic aorta[4]. SKF-83566 can be used for research of parkinson’s disease and nicotine craving alleviation[5].

   

2-hydroxy-6-(4-hydroxy-7-methyl-1,3-benzothiazol-6-yl)-4-methoxybenzoic acid

2-hydroxy-6-(4-hydroxy-7-methyl-1,3-benzothiazol-6-yl)-4-methoxybenzoic acid

C16H13NO5S (331.0514)


   

2-hydroxy-6-(4-hydroxy-6-methyl-1,3-benzothiazol-7-yl)-4-methoxybenzoic acid

2-hydroxy-6-(4-hydroxy-6-methyl-1,3-benzothiazol-7-yl)-4-methoxybenzoic acid

C16H13NO5S (331.0514)


   

(2r)-2-{[(2r,3r,4r,5r)-2-amino-4,5-dihydroxy-1-oxo-6-(phosphonooxy)hexan-3-yl]oxy}propanoic acid

(2r)-2-{[(2r,3r,4r,5r)-2-amino-4,5-dihydroxy-1-oxo-6-(phosphonooxy)hexan-3-yl]oxy}propanoic acid

C9H18NO10P (331.0668)


   

2-{[2-amino-4,5-dihydroxy-1-oxo-6-(phosphonooxy)hexan-3-yl]oxy}propanoic acid

2-{[2-amino-4,5-dihydroxy-1-oxo-6-(phosphonooxy)hexan-3-yl]oxy}propanoic acid

C9H18NO10P (331.0668)